Acne and Mood: Impact of Treatment on Depression, Anxiety, and Sexual Function
Status
Conditions
Treatments
Details and patient eligibility
About
This study seeks to examine if there is any relationship between spironolactone use prescribed for acne vulgaris and depression, anxiety, and/or sexual function.
Sex
Ages
Volunteers
Inclusion criteria
Female subjects between 18 and 65 years of age currently taking spironolactone for a diagnosis of acne vulgaris
OR
Female subjects between 18 and 65 years of age currently taking oral antibiotics for a diagnosis of acne vulgaris
AND Subjects able to complete an online survey in English
Exclusion criteria
Subjects less than 18 years of age or older than 65 years of age Subjects that have ever been diagnosed with any mood disorder by a clinician prior to starting spironolactone (history of mood disorder or current mood disorder) Subjects taking hormonal contraception (including but not limited to oral contraceptive pills) for a duration of less than 6 months Subjects that have ever been diagnosed with any type of sexual dysfunction prior to starting spironolactone Subjects not able to complete an online survey in English Subjects taking oral isotretinoin for a diagnosis of acne Subjects that are currently pregnant
Trial design
0 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal